Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial

Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial

<p><strong>Background</strong> The ICON8 study reported no significant improvement in progression-free survival (a primary endpoint) with weekly chemotherapy compared with standard 3-weekly treatment among patients with epithelial ovarian cancer. All ICON8 patients were eligible to...

Full description

Bibliographic Details
Main Authors: Blagden, S, Cook, AD, Poole, C, Howells, L, McNeish, IA, Dean, A, Kim, JW, O’Donnell, DM, Hook, J, James, EC, White, IR, Perren, T, Lord, R, Dark, G, Earl, HM, Hall, M, Kaplan, R, Ledermann, JA, Clamp, AR
Format: Journal article
Language:English
Published: Elsevier 2020

Similar Items

Similar Items